TRANSGENE Reports Fiscal Year 2013 Results And Provides Business Update

Published: Mar 27, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

Highlights from the consolidated financial results for 2013 included a stable net loss of €42.9 million compared to €43.2 million in 2012 and net cash burn of €45.0 million (€46.6 million in 2012). As of December 31, 2013, the Company had €47.9 million in cash, cash equivalents and other financial assets.

Help employers find you! Check out all the jobs and post your resume.

Back to news